// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

EVALUATION OF THE SICKKIDS TEAM OBESITY MANAGEMENT PROGRAM (STOMP)

Elizabeth Dettmer - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Depression

N/A

Severity of Growth Hormone (GH) Deficiency (GHD) Influences the Impact of the Exon 3-Deleted GH Receptor Polymorphism on Response to GH Therapy in Children with GHD

Peter Ellis Clayton - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

hGH

The EasypodTM Connect Observational Study (ECOS): Adherence Rates Before and After Study Enrollment

Jeremy Kirk - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Human growth hormone

Analysis of the direct regulation of reproductive-associated genes in hypothalamic kisspeptin-expressing neuronal cell models

Denise D Belsham - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Neuropeptides

The hormonal regulation of the novel reproductive peptide phoenixin in NPY and GnRH hypothalamic models by estrogen, insulin and leptin

Denise D Belsham - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alora

What is ?4H Syndrome? and how should the endocrinologist manage it?

Genevieve Bernard - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Alora

The 14-3-3Epsilon adaptor protein functions as a hormone-depended mitochondrial scaffold protein controlling TSPO-VDAC1 interactions and steroid formation in testis Leydig cells

Martine G Culty - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

pregnenolone

A Case of Rapidly Progressing Thyroid Goiter Associated with IgG4 Infiltration and Autoimmune Thyroid Disease

Antonio Maietta - Endocrine Society (ENDO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Autoimmune Thyroid Disease

N/A

Jefferson University Experience: Retrospective Analysis of Adrenal Incidentalomas

Hashim Kareemi - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Adrenal carcinoma

N/A

Ectopic ACTH Secretion from Metastatic Esthesioneuroblastoma: Limitations in Diagnosis and Treatment

Zachary Schwartz - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Somatostatin

Lxr? Antagonism Mitigates Glucocorticoid-Induced Gluconeogenesis without Altering Immune Suppression

Ricky Tsai - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory bowel disease

Glucocorticoid

Hepatic Ablation of Arginine and Glutamate Rich 1 Impairs Glucocorticoid-Induced Gluconeogenesis and Fatty Liver In Vivo

Rucha Patel - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Dyslipidemia

Glucocorticoid

Prolonged Hypothalamic-Pituitary-Adrenal Axis Activation after Acute Coronary Syndrome in the Genesis-Praxy Cohort

Doreen Rabi - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Peripheral artery disease

Glucocorticoid

Tumour-Induced Osteomalacia of the Cervical Spine: A Rare but Important Cause of Hypophosphatemia

Philippe Phan - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Tumor-induced osteomalacia

Alkaline phosphatase

Efficacy and Safety of Asfotase Alfa in Patients with Infantile Hypophosphatasia Treated for up to 3.5 Years: Results from a Phase II, Open-Label, Uncontrolled Study

Christine Hofmann - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypophosphatasia infantile type

Alkaline phosphatase

Multifactorial Assessment and Targeted Intervention to Prevent Recurrent Falls in Community Dwelling Elderly Individuals Presenting to Emergency Departments: a Systematic Review and Meta-Analysis

Minan Abbas - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Overview of the Etiology, Clinical Manifestations, Management Strategies and Complications of Hypoparathyroidism from the Canadian National Hypoparathyroidism Registry

Hamid Syed - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Pseudohypoparathyroidism

Hydrochlorothiazide

Treatment Effects of Modified-Release Calcifediol on Bone Markers Suggest Higher 25-Hydroxyvitamin D Levels Are Needed for Adequacy in Patients with Stage 3 or 4 CKD

Stephen Strugnell - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Secondary hyperparathyroidism

Alkaline phosphatase

Chronic High Dose Proton-Pump Inhibitors As a Cause of Hypophosphatemic Rickets

Marialena Mouzaki - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Hypophosphatemic rickets

Alkaline phosphatase

The Negative Effects of Staggered Palmitate Treatment on Glucose Responsiveness and Insulin Production in Mouse Beta Insulinoma Min6 Cells Are Reversible

Yuanyuan Nie - Endocrine Society (ENDO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Type 2 diabetes mellitus

hGH

Copyright © 2026. QuantiNova All rights reserved